Dr. Narezkina is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9434 Medical Center dr
La Jolla, CA 92037Phone+1 858-657-8530
Education & Training
- University of California (San Diego) Medical CenterFellowship, Cardiovascular Disease, 2011 - 2014
- University of California (San Diego) Medical CenterResidency, Internal Medicine, 2008 - 2010
- Smolensk State Medical AcademyClass of 2006
Certifications & Licensure
- CA State Medical License 2010 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- Low-dose CT-based Method for Detection of Subclinical Anthracycline-induced Cardiotoxicity Start of enrollment: 2018 Jan 09
Publications & Presentations
PubMed
- Predictors and Risk Score for Immune Checkpoint-Inhibitor-Associated Myocarditis Severity.John R Power, Charles Dolladille, Benay Ozbay, Adrien Md Procureur, Stephane Ederhy
Medrxiv. 2024-06-03 - 1 citationsRegional Strain of Right Ventricle From Computed Tomography Improves Risk Stratification of Right Ventricle Failure.Anderson Scott, Zhennong Chen, Seth Kligerman, Paul Kim, Hao Tran
ASAIO Journal. 2024-05-01 - Repotrectinib in a Patient WithFusion-Positive Pancreatic Carcinoma and Congenital Long QT Syndrome.Karen M Yun, Anna Narezkina, Charles Redfern, Katherine Velasco, Lyudmila Bazhenova
JCO Precision Oncology. 2024-01-01
Authored Content
- Healthy Lifestyle Reduces Leading Causes of Death WorldwideOctober 2022
Professional Memberships
- Member
Other Languages
- Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: